Trial Profile
A pilot, randomized trial to evaluate the lipid profile after antiretroviral regimens including nevirapine or atazanavir boosted with ritonavir in HIV-positive patients naive for antiretrovirals.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 13 Nov 2013
Price :
$35
*
At a glance
- Drugs Ritonavir (Primary) ; Atazanavir; Atazanavir/ritonavir; Emtricitabine; Emtricitabine/tenofovir disoproxil fumarate; Nevirapine; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Pharmacodynamics
- Acronyms STAR-2
- 16 Aug 2011 New trial record